---
document_datetime: 2023-09-21 18:38:26
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/aerinaze-epar-all-authorised-presentations_en.pdf
document_name: aerinaze-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0987043
conversion_datetime: 2025-12-30 09:02:56.119748
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented)   | Strength         | Pharmaceutical Form     | Route of       | Immediate Packaging     | Pack size   |
|------------------|--------------|------------------|-------------------------|----------------|-------------------------|-------------|
|                  | name         |                  |                         | Administration |                         |             |
| EU/1/07/399/001  | Aerinaze     | 2.5 mg / 120 mg* | Modified-release tablet | Oral use       | blister (PCTFE/PVC/alu) | 2 tablets   |
| EU/1/07/399/002  | Aerinaze     | 2.5 mg / 120 mg  | Modified-release tablet | Oral use       | blister (PCTFE/PVC/alu) | 4 tablets   |
| EU/1/07/399/003  | Aerinaze     | 2.5 mg / 120 mg  | Modified-release tablet | Oral use       | blister (PCTFE/PVC/alu) | 7 tablets   |
| EU/1/07/399/004  | Aerinaze     | 2.5 mg / 120 mg  | Modified-release tablet | Oral use       | blister (PCTFE/PVC/alu) | 10 tablets  |
| EU/1/07/399/005  | Aerinaze     | 2.5 mg / 120 mg  | Modified-release tablet | Oral use       | blister (PCTFE/PVC/alu) | 14 tablets  |
| EU/1/07/399/006  | Aerinaze     | 2.5 mg / 120 mg  | Modified-release tablet | Oral use       | blister (PCTFE/PVC/alu) | 20 tablets  |